Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in Rural Northeast China: 2008 to 2018

Table 2

Prevalence of normal, prehypertension, stage 1, stage 2, and stage 3 and their percentage change by sex in rural northeast China, 2008-2018.

Age groups (years)	Men			Women			Total			for men	for women	for total
	2008	2018	Change (%)	2008	2018	Change (%)	2008	2018	Change (%)
Normal
40-49	19.3	14.6	-24.0	33.9	28.6	-15.7	26.9	23.7	-11.7	0.003	<0.001	0.003
50-59	15.6	12.1	-22.6	21.8	14.2	-34.9	18.8	13.4	-28.7	0.001	<0.001	<0.001
60-69	13.0	9.1	-29.8	14.5	9.1	-37.4	13.8	9.1	-33.8	<0.001	<0.001	<0.001
70-79	10.1	4.0	-60.5	10.0	8.4	-16.1	10.1	6.4	-36.8	<0.001	0.14	<0.001
≥80	8.9	5.6	-37.7	7.4	4.0	-44.9	8.1	4.7	-41.9	0.192	0.128	0.042
Total	15.9	9.8	-38.4	23.9	14.1	-41.0	20.0	12.4	-38.0	<0.001	<0.001	<0.001
	15.9	11.6	-27.0	23.5	18.0	-23.4	19.9	15.8	-20.6
Prehypertension
40-49	52.8	40.5	-23.1	37.6	37.1	-1.2	44.9	38.3	-14.6	<0.001	0.745	<0.001
50-59	42.6	36.0	-15.3	32.1	34.4	7.3	37.1	35.0	-5.7	<0.001	0.028	0.015
60-69	33.6	28.4	-15.5	25.8	23.6	-8.2	29.7	25.7	-13.7	<0.001	0.036	<0.001
70-79	25.2	20.2	-20.0	20.8	14.7	-29.4	23.1	17.2	-25.5	0.003	<0.001	<0.001
≥80	24.1	21.5	-10.7	18.6	16.2	-12.8	21.4	18.6	-12.9	0.519	0.48	0.29
Total	42.8	30.7	-28.3	32.0	28.2	-11.9	37.3	29.2	-21.7	<0.001	<0.001	<0.001
ASR	42.9	34.6	-19.3	31.4	30.8	-1.9	37.0	32.3	-12.7
Stage 1
40-49	18.5	27.6	49.5	16.7	22.5	34.9	17.5	24.3	38.5	<0.001	<0.001	<0.001
50-59	24.1	29.4	21.7	23.3	27.2	16.6	23.7	28.0	18.1	<0.001	<0.001	<0.001
60-69	27.8	31.5	13.1	26.4	31.6	19.5	27.1	31.5	16.2	0.002	<0.001	<0.001
70-79	30.8	34.9	13.2	27.1	28.2	4.4	29.0	31.3	7.9	0.024	0.468	0.059
≥80	31.5	34.0	8.0	25.3	27.2	7.2	28.4	30.3	6.5	0.564	0.634	0.528
Total	23.5	31.0	31.9	21.7	27.9	28.6	22.6	29.2	29.2	<0.001	<0.001	<0.001
ASR	23.3	29.7	27.5	21.7	26.2	20.7	22.5	27.5	22.2
Stage 2
40-49	6.2	12.2	95.6	7.8	8.2	4.2	7.1	9.6	35.5	<0.001	0.673	<0.001
50-59	11.6	16.2	39.4	14.3	16.9	17.9	13.0	16.6	27.7	<0.001	0.002	<0.001
60-69	16.9	21.6	27.6	20.6	21.9	6.3	18.7	21.7	16.1	<0.001	0.17	<0.001
70-79	21.5	25.5	18.8	24.4	29.4	20.2	22.9	27.6	20.5	0.012	0.002	<0.001
≥80	19.7	22.9	16.1	27.9	29.5	5.8	23.8	26.5	11.5	0.401	0.681	0.319
Total	11.6	19.4	67.2	13.9	18.9	36.0	12.8	19.1	49.2	<0.001	<0.001	<0.001
ASR	11.5	16.6	44.3	14.5	16.1	11.0	13.0	16.1	23.8
Stage 3
40-49	3.3	5.0	52.3	4.0	3.6	-9.4	3.6	4.1	12.3	0.015	0.515	0.31
50-59	6.1	6.3	3.8	8.6	7.4	-13.9	7.4	7.0	-5.3	0.744	0.062	0.41
60-69	8.7	9.5	9.0	12.7	13.8	8.7	10.7	12.0	12.1	0.297	0.153	0.017
70-79	12.3	15.4	24.8	17.7	19.3	9.0	14.9	17.5	17.5	0.019	0.256	0.007
≥80	15.7	16.0	1.4	20.9	23.1	10.7	18.3	19.9	8.6	0.948	0.536	0.527
Total	6.2	9.2	48.4	8.4	10.8	28.6	7.3	10.2	39.7	<0.001	<0.001	<0.001
ASR	6.3	7.5	19.0	8.9	8.9	0.0	7.6	8.2	7.9